Ciprodex · DIN 02252716 · 0.3% w/v & 0.1% w/v · Otic suspension-7.5mL Pk (With Preservative)
Limited Use, Reason for Use code 509 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 509 required
Write on scriptReason for Use code 509 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 509
Reason for Use code 509
The treatment of otitis externa in patients:
- With known perforated tympanic membrane or ventilation tubes;
OR
- Requiring chronic therapy (i.e., more than 14 days);
OR
- Who have been receiving more than 7 days of topical aminoglycoside therapy without improvement, where there is concern of a resistant pathogen;
OR
- With documented pre-existing hearing impairment.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Ciprodex · DIN 02252716
Manufacturer: Novartis Pharma Canada Inc.; listing date 2018-06-29
Health Canada: Marketed since 2018-06-11 · brand CIPRODEX · ATC S02CA06 DEXAMETHASONE AND ANTIINFECTIVES · form Suspension · route Otic · ingredients CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %/W/V, DEXAMETHASONE 0.1 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252716)
Source record
DIN 02252716: Ciprodex
Raw flags: sec12=Y, sec3=Y
Item: 520404046; group id 575; item number 1529; lccId 00306; manufacturer id NOV
Source form: Otic Susp-7.5mL Pk (With Preservative); strength: 0.3% w/v & 0.1% w/v
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $32.6094; ministry $14.4203
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252716
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73758
Interchangeable products
Sandoz Ciprofloxacin/Dexamethasone · DIN 02506882 · $14.4203
Taro-Ciprofloxacin/Dexamethasone · DIN 02481901 · $14.4203
Shortage status: not checked (no credentials)